Topical Bethanechol for Improvement of Esophageal Dysmotility
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this research project is to determine the effect of a drug called bethanechol
on swallowing function in patients with Ineffective Esophageal Motility (IEM). This drug is
FDA approved for use in treating other conditions, but not for the treatment of IEM. There is
currently no approved therapy for the treatment of IEM. This information is important for the
possible development of new ways of treating patients with IEM and for the effectiveness of
topically applied Bethanechol on patients with IEM.